NervGen Pharma Corp. (NGENF)
OTCMKTS · Delayed Price · Currency is USD
2.730
+0.180 (7.06%)
Sep 5, 2025, 3:59 PM EDT
NervGen Pharma Market Cap
NervGen Pharma has a market cap or net worth of $200.24 million as of September 5, 2025. Its market cap has increased by 36.02% in one year.
Market Cap
200.24M
Enterprise Value
188.95M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.73
Market Cap Chart
Since March 15, 2019, NervGen Pharma's market cap has increased from 37.55M to 200.24M, an increase of 433.29%. That is a compound annual growth rate of 29.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 200.24M | 30.51% |
| Dec 31, 2024 | 153.43M | 25.91% |
| Dec 29, 2023 | 121.86M | 75.67% |
| Dec 30, 2022 | 69.37M | -29.11% |
| Dec 31, 2021 | 97.86M | 59.23% |
| Dec 31, 2020 | 61.46M | 38.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 760.21M |
| Tian'an Technology Group | 673.67M |
| Glass House Brands | 600.00M |
| HealthLynked | 499.79M |
| CytoDyn | 401.20M |
| Northwest Biotherapeutics | 387.41M |